Wyost® (denosumab-bbdz) – First-time interchangeable biosimilar launch

<style type="text/css">.columns-container__full-width-background.banner__main-hero.background__main-hero {background-image: url("undefined")}@media only screen and (min-width:769px) { .columns-container__full-width-background.banner__main-hero.background__main-hero { background-image: url("undefined")}}</style>

Dynamic Alerts

Site Logo

Health care professionals website

DPL Global Search

DPL Main Nav

DPL Global Search

Breadcrumbs

Text

Wyost® (denosumab-bbdz) – First-time interchangeable biosimilar launch

June 2, 2025 - Sandoz launched Wyost (denosumab-bbdz), biosimilar and interchangeable to Amgen’s Xgeva® (denosumab).

Text

Return to publications

Top